Nuforce-CD 3 Tablets

babies: not applicable lactating mother: safe if prescribed by your doctor because human studies have shown no evidence of side effects to the baby. pregnancy: safe if prescribed by your doctor because animal studies have shown no risk to the developing baby. driving: no interactions found. alcohol: no interactions found. kidney: no interactions found. liver: no interactions found..

Vaginal burning sensation Itching Irritation .

NUFORCE CD works by fighting against the infection by stopping the growth of infection-causing microorganisms and preventing infection spread..

If you miss a dose of NUFORCE CD, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• do not skip any doses and finish the full course of treatment even if you feel better. • avoid contact with your eyes. if accidental exposure occurs, rinse immediately with water.
• NUFORCE CD may cause minor burning sensation, stinging or irritation while applying. inform your doctor if these symptoms do not get improved within 3 days of taking this suppository. • it can damage condoms & diaphragms and make them ineffective in preventing pregnancy.
ask your doctor about other suitable methods of preventing pregnancy..

contraindicated • clindamycin phosphate + typhoid vaccine: concurrent use leads to increase in clindamycin phosphate levels by decreasing typhoid vaccine levels. • clindamycin phosphate + bcg vaccine: concurrent use leads to increase in clindamycin phosphate levels by decreasing bcg vaccine. • clotrimazole + everolimus: concurrent use leads to increase in clotrimazole levels by decreasing everolimus. serious • clindamycin phosphate + atracurium: concurrent use leads to increase in atracurium levels by decreasing clindamycin phosphate. • clindamycin phosphate + pancuronium: concurrent use leads to increase in pancuronium levels by decreasing clindamycin phosphate. • clotrimazole + axitinib: concurrent use leads to increase in axitinib levels by decreasing clotrimazole. monitor closely • clindamycin phosphate + digoxin: concurrent use leads to increase in digoxin levels by decreasing clindamycin phosphate. • clotrimazole + amikacin: concurrent use leads to increase in clotrimazole levels by decreasing amikacin.
minor • clindamycin phosphate + pyridoxine: concurrent use leads to increase in clindamycin phosphate levels by decreasing pyridoxine. • clotrimazole + phenobarbital: concurrent use leads to increase in phenobarbital levels by decreasing clotrimazole.
.